Evidence map›Paper›PMID 37645381›Full record

ArticleFrontiers in cellular and infection microbiology2023

Corrigendum: Microbiological diagnostic performance of metagenomic next-generation sequencing compared with conventional culture for patients with community-acquired pneumonia.

Tianlai Lin, Xueliang Tu, Jiangman Zhao, Ling Huang, Xiaodong Dai, Xiaoling Chen, Yue Xu, Wushuang Li, Yaoyao Wang, Jingwei Lou and 2 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

Tianlai LinDepartment of Intensive Care Unit, Quanzhou First Hospital Affiliated to Fujian Medical University, Quanzhou, China.
Xueliang TuDepartment of Clinical Laboratory, Huanghe Sanmenxia Hospital Affiliated to Henan University of Science and Technology, Sanmenxia, China.
Jiangman ZhaoShanghai Biotecan Pharmaceuticals Co., Ltd., Shanghai, China.
Ling HuangDepartment of Intensive Care Unit, Quanzhou First Hospital Affiliated to Fujian Medical University, Quanzhou, China.
Xiaodong DaiDepartment of Intensive Care Unit, Quanzhou First Hospital Affiliated to Fujian Medical University, Quanzhou, China.
Xiaoling ChenDepartment of Intensive Care Unit, Quanzhou First Hospital Affiliated to Fujian Medical University, Quanzhou, China.
Yue XuShanghai Biotecan Pharmaceuticals Co., Ltd., Shanghai, China.
Wushuang LiShanghai Biotecan Pharmaceuticals Co., Ltd., Shanghai, China.
Yaoyao WangShanghai Biotecan Pharmaceuticals Co., Ltd., Shanghai, China.
Jingwei LouShanghai Biotecan Pharmaceuticals Co., Ltd., Shanghai, China.
Shouxin WuShanghai Biotecan Pharmaceuticals Co., Ltd., Shanghai, China.
Hongling ZhangDepartment of Intensive Care Unit, Quanzhou First Hospital Affiliated to Fujian Medical University, Quanzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

[This corrects the article DOI: 10.3389/fcimb.2023.1136588.].

Indexed as

community-acquired pneumoniaconventional microbiological testculturemetagenomic next-generation sequencingpathogen detection

Identifiers

PMID37645381
PMCPMC10461624

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.